The effect of dobutamine on ocular blood flow of healthy adults: A 3D pseudocontinuous aterial spin labelling study

Linkun Cai1, Haijun Niu1, Pengling Ren2

  • 1School of Biological Science and Medical Engineering, Beihang University, Beijing, China.

Frontiers in Physiology
|December 16, 2022
PubMed

Insights

Dobutamine significantly increased ocular blood flow (OBF) in healthy adults. This finding suggests dobutamine may be a potential therapeutic option for conditions involving ocular vascular ischemia.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Medical Imaging

Background:

  • Ocular blood flow (OBF) is crucial for preventing and managing various eye diseases.
  • Limited therapeutic strategies currently exist to enhance OBF.

Purpose of the Study:

  • To evaluate the impact of dobutamine on OBF in healthy adults.
  • To identify risk factors influencing OBF.

Main Methods:

  • Utilized 3D pseudocontinuous arterial spin labelling (3D-pcASL) with 3.0T-MRI to measure OBF.
  • Administered intravenous dobutamine to 43 healthy participants.
  • Collected concurrent physiological data.

Main Results:

  • OBF significantly increased post-dobutamine administration (22.43 ± 9.87 to 47.73 ± 14.02 ml/min/100g, p < 0.001).
  • Age, heart rate, and systolic blood pressure were identified as significant risk factors for OBF.

Conclusions:

  • This is the first study to demonstrate dobutamine's effect on OBF.
  • Intravenous dobutamine effectively increases OBF, presenting a potential future treatment for ocular vascular ischemia.